

Welcome to the Journal of AI and Integrative Medicine (JAIIM), an international, peer-reviewed, open-access journal published by Novadex Publications.
JAIIM provides a multidisciplinary platform for the publication of high-quality research that advances the integration of Artificial Intelligence (AI) with medicine, healthcare, biomedical sciences, digital health, and integrative medicine. The journal welcomes innovative research that contributes to improving patient care, healthcare systems, clinical decision-making, disease prevention, precision medicine, and public health through interdisciplinary scientific collaboration.
The journal publishes original, scientifically rigorous, ethically conducted, and clinically relevant research. All submitted manuscripts undergo a rigorous Double-Blind Peer Review process conducted by independent experts before editorial decisions are made.
Authors are encouraged to carefully read these guidelines before submitting a manuscript. Compliance with these instructions will facilitate efficient editorial processing and peer review.
JAIIM follows internationally recognized publishing standards and adheres to the recommendations of:
Committee on Publication Ethics (COPE)
International Committee of Medical Journal Editors (ICMJE)
Directory of Open Access Journals (DOAJ)
Principles of Transparency and Best Practice in Scholarly Publishing
World Association of Medical Editors (WAME), where applicable
The Journal of AI and Integrative Medicine (JAIIM) publishes high-quality scholarly research that explores the application of artificial intelligence and emerging technologies in medicine, healthcare, and integrative health sciences.
The journal welcomes interdisciplinary research that bridges computational sciences with clinical and biomedical applications.
Areas of interest include, but are not limited to:
Machine Learning
Deep Learning
Explainable AI
Clinical Decision Support Systems
Medical Expert Systems
Natural Language Processing
Generative AI in Healthcare
AI Ethics in Medicine
Health Informatics
Electronic Health Records
Telemedicine
Remote Patient Monitoring
Mobile Health (mHealth)
Wearable Technologies
Digital Therapeutics
Healthcare Data Analytics
Computer-Aided Diagnosis
Medical Image Analysis
Radiomics
Pathology Image Analysis
Computer Vision in Medicine
AI-Assisted Diagnostic Systems
Precision Medicine
Genomic Medicine
Multi-omics Integration
Biomarker Discovery
Predictive Analytics
Personalized Healthcare
Evidence-Based Integrative Medicine
Complementary Medicine
Traditional Medicine
Lifestyle Medicine
Nutrition Science
Mind-Body Medicine
Integrative Oncology
Preventive Healthcare
Medical Devices
Biosensors
Biomedical Signal Processing
Robotics in Medicine
Rehabilitation Technologies
Smart Healthcare Systems
Precision Public Health
Epidemiology
Population Health
Health Policy
Disease Surveillance
AI for Global Health
Clinical Trials
Observational Studies
Translational Medicine
Health Services Research
Evidence-Based Medicine
Comparative Effectiveness Research
Interdisciplinary research that combines multiple fields is particularly encouraged.
JAIIM accepts the following categories of manuscripts.
Reports of original scientific investigations presenting novel findings.
Recommended length:
3,000–8,000 words
Up to 10 figures or tables
Structured abstract
No fixed limit on references where scientifically justified
Comprehensive and critical reviews summarizing current evidence and future research directions.
Recommended length:
4,000–10,000 words
Systematic evidence syntheses prepared according to internationally recognized reporting standards such as PRISMA.
Brief reports describing important preliminary findings, innovative methods, or significant observations.
Recommended length:
Up to 2,500 words
Clinically important or educationally valuable case reports that provide novel insights into diagnosis, treatment, AI-assisted clinical decision-making, or integrative medicine.
Authors are encouraged to follow the CARE reporting guidelines.
Reports describing multiple patients with similar clinical presentations or interventions.
Reports of completed clinical trials should follow the CONSORT Statement and include clinical trial registration details where applicable.
Descriptions of innovative methodologies, computational models, software tools, laboratory techniques, or analytical frameworks.
Brief descriptions of innovative technologies, algorithms, software, medical devices, or engineering developments.
Protocols describing planned clinical studies or research projects of significant scientific value.
Expert opinions discussing emerging trends, challenges, and future directions.
Short articles providing scholarly discussion of recently published research or current issues.
Invited articles written by editors or invited experts.
Short communications discussing recently published articles or issues relevant to the journal's scope.
Authors submitting manuscripts to JAIIM must ensure that:
The manuscript is original.
The work has not been published previously.
The manuscript is not under consideration by another journal.
All authors approve the submission.
Appropriate ethical approvals have been obtained where required.
All conflicts of interest have been disclosed.
Funding information has been provided.
All references are accurate and complete.
AI-assisted tools used during manuscript preparation have been disclosed where applicable.
Submissions that do not comply with these requirements may be returned before peer review.
Manuscripts should be prepared in clear, concise, and grammatically correct English.
Authors are encouraged to use either British or American English consistently throughout the manuscript.
Recommended file format:
Microsoft Word (.doc or .docx)
General formatting recommendations:
A4 page size
12-point Times New Roman font
Double line spacing
Continuous page numbering
Continuous line numbering (recommended)
Standard margins of 2.5 cm (1 inch) on all sides
Left-aligned text
Automatic page numbering
Scientific names should be italicized where appropriate.
Standard International System of Units (SI Units) should be used throughout the manuscript.
Abbreviations should be defined at first mention and used consistently thereafter.
The Title Page should be submitted as a separate file to preserve the integrity of the double-blind peer review process.
The Title Page should include:
Full manuscript title
Running title (maximum 50 characters)
Full names of all authors
Institutional affiliations
ORCID iDs (recommended)
Corresponding author's name
Corresponding author's email address
Postal address
Telephone number (optional)
Funding information
Conflict of Interest statement
Author contribution statement
Acknowledgements (if applicable)
For correspondence regarding manuscripts, please contact:
Editorial Office
Journal of AI and Integrative Medicine (JAIIM)
Novadex Publications
Email: editor@novadexpub.com
Every manuscript submitted to the Journal of AI and Integrative Medicine (JAIIM) must include an abstract and keywords.
The abstract should provide a concise summary of the study and accurately reflect the content of the manuscript.
A structured abstract of 250–350 words should include the following headings:
Background
Objectives
Methods
Results
Conclusions
The abstract should not contain:
References
Figures or tables
Undefined abbreviations
Citations
Review articles should include an unstructured abstract of approximately 200–300 words summarizing the purpose, key findings, and conclusions.
Case reports should include a concise abstract describing:
Background
Case Presentation
Clinical Outcome
Clinical Significance
Authors should provide 3–8 keywords immediately below the abstract.
Keywords should:
Reflect the major topics of the manuscript.
Use internationally recognized terminology.
Preferably correspond to Medical Subject Headings (MeSH) where appropriate.
The manuscript should generally be organized in the following order:
Title
Abstract
Keywords
Introduction
Materials and Methods
Results
Discussion
Conclusion
Acknowledgements (optional)
Funding Statement
Conflict of Interest Statement
Author Contributions
Data Availability Statement
Ethical Approval Statement
Informed Consent Statement (where applicable)
References
Tables
Figure Legends
Supplementary Material (if applicable)
Different article types may require minor modifications to this structure.
Original Research Articles should generally follow the IMRAD format.
The Introduction should:
Present the scientific background.
Summarize relevant literature.
Identify existing knowledge gaps.
Clearly state the study objectives or hypotheses.
Avoid an extensive literature review.
This section should provide sufficient detail to allow replication of the study.
Include information on:
Study design
Study setting
Participants or samples
Inclusion and exclusion criteria
Data collection methods
Experimental procedures
Equipment and software
AI models or algorithms (where applicable)
Statistical analysis
Ethical approval
Clinical trial registration (if applicable)
Authors should provide sufficient methodological detail to support reproducibility.
Present findings clearly without interpretation.
Results may include:
Tables
Figures
Graphs
Statistical analyses
Confidence intervals
Effect sizes
Performance metrics for AI models (e.g., Accuracy, Precision, Recall, F1-score, AUROC) where appropriate
Avoid repeating the same data in both tables and figures.
The Discussion should:
Interpret the findings.
Compare results with previous studies.
Explain clinical or scientific significance.
Discuss strengths and limitations.
Suggest future research directions.
Avoid repeating numerical results already presented.
The Conclusion should:
Summarize the principal findings.
Highlight the significance of the study.
Avoid introducing new data.
Clearly state the implications for research, clinical practice, or healthcare policy where appropriate.
Tables should:
Be created using the table function of the word processor.
Be numbered consecutively (Table 1, Table 2, etc.).
Include concise titles.
Be cited in the text.
Avoid duplication of data presented elsewhere.
Footnotes should explain abbreviations and statistical symbols.
Figures should be of high quality and suitable for publication.
Recommended formats include:
TIFF
PNG
JPEG
EPS (where appropriate)
Recommended minimum resolution:
300 dpi for photographs
600 dpi for line artwork
1200 dpi for graphs and diagrams where possible
Each figure should:
Be numbered consecutively.
Include a descriptive legend.
Be cited in the manuscript.
Authors are responsible for obtaining permission to reproduce copyrighted material.
Supplementary files may include:
Additional datasets
Large tables
Computer code
Software documentation
Multimedia files
Video demonstrations
AI model documentation
Extended methodological descriptions
Supplementary material should enhance—but not replace—the main manuscript.
Equations should:
Be prepared using an equation editor.
Be numbered consecutively when referenced.
Define all variables upon first use.
Mathematical notation should remain consistent throughout the manuscript.
Authors are responsible for ensuring that all references are:
Accurate
Complete
Current
Relevant
Cited appropriately within the text
Where available, authors are encouraged to include:
DOI numbers
PubMed IDs
URLs for publicly accessible datasets
References should primarily consist of peer-reviewed scholarly literature.
Authors should avoid excessive self-citation or inappropriate citation practices.
JAIIM currently follows the Vancouver Citation Style, widely used in biomedical and medical journals.
Examples:
Author AB, Author CD. Title of article. Journal Name. Year;Volume(Issue):Pages. doi:xxxxx
Author AB. Book Title. Edition. Publisher; Year.
Author AB. Chapter title. In: Editor CD, editor. Book Title. Publisher; Year. p. xx–xx.
Organization Name. Title of webpage. Available from: URL. Accessed Month Day, Year.
Authors should verify every reference before submission.
Authors should prepare manuscripts in accordance with internationally recognized reporting guidelines whenever applicable.
Examples include:
| Study Type | Reporting Guideline |
|---|---|
| Randomized Controlled Trials | CONSORT |
| Systematic Reviews | PRISMA |
| Observational Studies | STROBE |
| Case Reports | CARE |
| Animal Studies | ARRIVE |
| Prediction Models | TRIPOD |
| Diagnostic Accuracy Studies | STARD |
| Qualitative Research | COREQ |
| Clinical Trial Protocols | SPIRIT |
| Health Economic Evaluations | CHEERS |
Editors may request completed reporting guideline checklists during editorial assessment.
Compliance with these reporting standards improves transparency, reproducibility, and scientific quality.
Authors are responsible for submitting manuscripts written in clear, grammatically correct English.
If English is not the authors' first language, professional language editing before submission is strongly recommended.
Language editing does not guarantee acceptance but may facilitate peer review and editorial evaluation.
The Journal of AI and Integrative Medicine (JAIIM) is committed to maintaining the highest standards of research integrity and publication ethics.
All submitted manuscripts must comply with internationally recognized ethical principles, including the recommendations of:
Committee on Publication Ethics (COPE)
International Committee of Medical Journal Editors (ICMJE)
Declaration of Helsinki (for human research)
World Medical Association (WMA)
Directory of Open Access Journals (DOAJ)
Applicable national and institutional ethical regulations
Authors are responsible for ensuring that all research has been conducted ethically and legally.
Research involving human participants must comply with internationally accepted ethical standards.
Authors must include:
Name of the approving Ethics Committee or Institutional Review Board (IRB)
Ethics approval number (where applicable)
Date of approval (if available)
Statement confirming compliance with the Declaration of Helsinki
Example:
Ethics Approval: This study was approved by the Institutional Ethics Committee of XYZ University (Approval No. IEC/2026/015).
For studies involving human participants, authors must confirm that informed consent was obtained before participation.
Where applicable, manuscripts should include statements regarding:
Written informed consent
Publication consent for identifiable information or images
Protection of participant confidentiality
Personal information capable of identifying participants should not be published unless explicit written consent has been obtained.
Studies involving animals must comply with institutional, national, and international animal welfare guidelines.
Authors should provide:
Name of the Animal Ethics Committee
Approval number
Confirmation that animal suffering was minimized
Compliance with recognized animal welfare standards
The journal reserves the right to request supporting ethical documentation.
Prospective clinical trials should be registered in a publicly accessible clinical trial registry before enrollment of the first participant.
Acceptable registries include:
ClinicalTrials.gov
Clinical Trials Registry–India (CTRI)
ISRCTN Registry
EU Clinical Trials Register
WHO International Clinical Trials Registry Platform (ICTRP) approved registries
The manuscript should include:
Registry name
Registration number
Registration date
Failure to register applicable clinical trials may affect editorial consideration.
Authors may use Artificial Intelligence (AI) tools solely to improve:
Language quality
Grammar
Readability
Coding assistance
Data visualization
Literature organization
Authors must disclose any use of AI tools within the manuscript.
Example disclosure:
"The authors used an AI-assisted language editing tool to improve grammar and readability. All scientific content, interpretation, analysis, and conclusions were prepared and verified by the authors."
AI systems:
Cannot be listed as authors.
Cannot assume responsibility for published work.
Cannot approve manuscripts.
Cannot hold copyright.
Authors remain fully responsible for every aspect of the manuscript.
Images, figures, videos, datasets, or graphical abstracts generated wholly or partly using AI technologies must be clearly disclosed.
Authors should describe:
The AI software used
Version (if available)
Purpose of AI use
Any subsequent human editing or verification
AI-generated content must not misrepresent research findings or fabricate scientific evidence.
Editors may request original source files during peer review.
Every research article should include a Data Availability Statement.
Examples include:
Data are available within the manuscript and supplementary files.
Data are available from the corresponding author upon reasonable request.
Data have been deposited in a public repository.
Data cannot be shared due to ethical, legal, or confidentiality restrictions.
Authors are encouraged to deposit datasets in recognized repositories whenever possible.
Authors must disclose all sources of financial support.
The Funding Statement should include:
Funding agency
Grant number (if applicable)
Role of the funding organization in the research
If no funding was received, authors should state:
"The authors received no external funding for this research."
All authors must disclose any financial or non-financial relationships that could influence the research.
Examples include:
Employment
Consultancy
Honoraria
Stock ownership
Patents
Advisory board membership
Personal relationships
Institutional affiliations
If no conflicts exist, authors should state:
"The authors declare no conflicts of interest."
JAIIM encourages the use of the CRediT (Contributor Roles Taxonomy) to describe individual author contributions.
Examples include:
Conceptualization
Methodology
Software
Validation
Formal Analysis
Investigation
Data Curation
Writing – Original Draft
Writing – Review & Editing
Visualization
Supervision
Project Administration
Funding Acquisition
All authors should approve the submitted contribution statement.
JAIIM strongly encourages all authors to register for an Open Researcher and Contributor ID (ORCID).
Providing an ORCID iD:
Improves author identification.
Enhances discoverability.
Facilitates accurate attribution of scholarly work.
Supports research integrity.
Authors may include their ORCID iDs on the Title Page.
Individuals or organizations who contributed to the work but do not meet authorship criteria should be acknowledged.
Examples include:
Technical assistance
Statistical consultation
Language editing
Administrative support
Laboratory assistance
Authors must obtain permission from acknowledged individuals before publication.
Authors retain copyright of their published work.
Upon acceptance, authors grant the Journal of AI and Integrative Medicine (JAIIM) and Novadex Publications a non-exclusive license to publish, archive, preserve, and disseminate the article.
Authors remain free to:
Share the published article.
Deposit the article in institutional repositories.
Include the work in theses or dissertations.
Reuse the work in future publications with appropriate citation.
JAIIM is a fully Open Access journal.
All published articles are made immediately and permanently available online without subscription fees or access restrictions.
Readers may:
Read
Download
Copy
Share
Cite
Link to
Reuse articles
subject to the terms of the applicable Creative Commons license.
Unless otherwise stated, all articles published in JAIIM are distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License.
This license permits:
Sharing
Distribution
Adaptation
Reproduction
Commercial and non-commercial reuse
provided appropriate credit is given to the original authors and the journal, a link to the license is included, and any modifications are indicated.
If authors reproduce copyrighted material from another source, they must obtain written permission from the copyright holder before submission.
Authors are responsible for submitting evidence of permission upon request.
Failure to obtain necessary permissions may delay publication or result in rejection.
The Journal of AI and Integrative Medicine (JAIIM) is an international, peer-reviewed, fully Open Access journal published by Novadex Publications.
To support the costs associated with manuscript processing, peer review management, copyediting, typesetting, DOI registration, online publication, website maintenance, long-term digital preservation, and dissemination of scholarly content, an Article Processing Charge (APC) is payable only after a manuscript has been accepted for publication.
There are no submission charges. Authors are not required to pay any fee during manuscript submission or peer review.
| Author Category | APC |
|---|---|
| Authors affiliated with institutions in India | ₹2,000 (INR) |
| International Authors (outside India) | USD$60 |
The applicable APC is determined based on the affiliation of the corresponding author at the time of manuscript submission.
The APC contributes to the costs of:
Initial manuscript screening
Editorial assessment
Double-blind peer review management
Plagiarism screening
Professional copyediting
Language and formatting checks
Typesetting and article production
DOI registration
Online publication
Open Access hosting
Long-term digital preservation
Website maintenance
Indexing metadata preparation
Payment of the APC does not guarantee acceptance or publication.
Editorial decisions are made independently by the Editor-in-Chief and Editorial Board based solely on:
Scientific quality
Originality
Methodological rigor
Ethical compliance
Relevance to the journal's scope
Peer reviewer recommendations
The editorial process is completely independent of financial considerations.
Authors will receive APC payment instructions only after the manuscript has been formally accepted.
Payment should not be made before acceptance unless specifically requested by the Editorial Office.
JAIIM supports equitable access to scholarly publishing.
Authors who are unable to pay the APC due to genuine financial hardship may submit a written request for a full or partial waiver.
Waiver requests are evaluated confidentially and independently of the editorial process.
Approval or rejection of a waiver request has no effect on the editorial evaluation or publication decision.
Once editorial processing and production have commenced following acceptance, APC payments are generally non-refundable.
Refunds may only be considered in exceptional circumstances at the discretion of the Publisher.
Authors are responsible for any applicable:
Bank transfer charges
Currency conversion fees
Taxes imposed by their financial institution or country
All published articles are made immediately and permanently available under the Creative Commons Attribution 4.0 International (CC BY 4.0) License.
Authors retain copyright while granting the journal a non-exclusive license to publish and disseminate their work.
For APC-related questions, payment instructions, or waiver requests, please contact:
Editorial Office
Journal of AI and Integrative Medicine (JAIIM)
Novadex Publications
Email: editor@novadexpub.com
36. Waiver Policy
JAIIM is committed to supporting high-quality research from around the world.
Authors who are unable to pay the APC due to financial constraints may request a full or partial waiver before or during manuscript submission.
Waiver requests are evaluated independently of the peer review process.
Granting a waiver has no influence on editorial decisions.
All manuscripts must be submitted electronically through the Open Journal Systems (OJS) manuscript submission system.
Authors should:
Register for an author account.
Complete all required submission steps.
Upload manuscript files.
Upload the Title Page separately.
Provide metadata for all authors.
Upload supplementary files where applicable.
Confirm compliance with journal policies.
Complete all required declarations before final submission.
Incomplete submissions may be returned for correction before editorial evaluation.
Depending on the article type, authors should submit:
Main manuscript (anonymous)
Separate Title Page
Cover Letter
Tables
Figures
Supplementary Material (if applicable)
Graphical Abstract (optional)
Ethics Approval documentation (if requested)
Clinical Trial Registration information (where applicable)
Reporting Guideline Checklist (when applicable)
Conflict of Interest Declaration
Copyright or License Agreement (after acceptance)
A cover letter should accompany every submission.
The cover letter should briefly describe:
The importance of the study.
Why the manuscript fits the scope of JAIIM.
Confirmation that the work is original.
Confirmation that the manuscript is not under consideration elsewhere.
Disclosure of conflicts of interest.
Any additional information relevant to the editors.
Following submission, manuscripts typically proceed through the following stages:
Initial Editorial Screening
Scope Assessment
Technical Compliance Check
Plagiarism Screening
Assignment to Handling Editor
Reviewer Invitation
Double-Blind Peer Review
Editorial Decision
Author Revision (if required)
Final Acceptance
Copyediting
Typesetting
Author Proof Review
Online Publication
DOI Registration
Indexing and Archiving
Authors may monitor the progress of their manuscripts through the OJS submission system.
Based on reviewer reports and editorial evaluation, one of the following decisions may be issued:
Accept
Accept with Minor Revisions
Major Revisions Required
Reject
The Editor-in-Chief reserves the right to make the final editorial decision.
Following acceptance, authors will receive page proofs for review.
Authors should:
Review proofs carefully.
Correct typographical errors.
Verify author names and affiliations.
Check figures and tables.
Confirm reference accuracy.
Substantive changes to the scientific content are generally not permitted at the proof stage without editorial approval.
Authors should return corrected proofs promptly to avoid publication delays.
Accepted manuscripts are published online as soon as the production process is completed.
Each published article receives:
Final citation information.
A permanent Digital Object Identifier (DOI).
Open Access availability under the journal's licensing policy.
Publication schedules may vary depending on editorial workflow and production requirements.
Every published article receives a permanent Digital Object Identifier (DOI) through the journal's registration agency.
The DOI provides:
Persistent article identification.
Reliable citation.
Long-term discoverability.
Stable online access.
Authors are encouraged to use the DOI when citing published articles.
JAIIM is committed to the long-term preservation of scholarly content.
Published articles are preserved through:
PKP Preservation Network (where implemented)
Institutional backups
Publisher archives
Additional trusted digital preservation services as adopted by the journal
These preservation measures help ensure permanent accessibility of published research.
When necessary, JAIIM may publish:
Corrections (Errata)
Corrigenda
Expressions of Concern
Retractions
Such actions are undertaken in accordance with the journal's Publication Ethics Policy and COPE recommendations to maintain the integrity of the scholarly record.
JAIIM actively seeks inclusion in recognized indexing and abstracting databases to maximize the visibility and impact of published research.
The journal will pursue indexing in appropriate national and international databases as it meets the eligibility requirements of each service.
Information regarding current indexing status will be maintained on the journal website.
The journal is committed to promoting responsible research and publication practices.
Authors are expected to avoid:
Plagiarism
Data fabrication
Data falsification
Duplicate publication
Image manipulation
Citation manipulation
Undisclosed conflicts of interest
Inappropriate authorship practices
Any suspected research misconduct will be investigated in accordance with the journal's Publication Ethics Policy and COPE guidance.
Before submitting a manuscript, authors should ensure that:
The manuscript is original.
The manuscript fits the journal's aims and scope.
The work has not been published previously.
The manuscript is not under review elsewhere.
All authors have approved the submission.
Ethical approval has been obtained where required.
Informed consent has been obtained where applicable.
Clinical trial registration information has been provided, if applicable.
Funding sources have been disclosed.
Conflicts of interest have been declared.
AI-assisted tools have been disclosed where applicable.
References are complete and accurate.
Tables and figures are correctly numbered and cited.
Reporting guideline checklists have been completed where applicable.
The manuscript complies with all journal formatting requirements.
For questions regarding manuscript preparation, submission, editorial policies, or the publication process, please contact:
Editorial Office
Journal of AI and Integrative Medicine (JAIIM)
Novadex Publications
Email: editor@novadexpub.com
The Journal of AI and Integrative Medicine (JAIIM) is dedicated to publishing high-quality, innovative, and ethically conducted research that advances the fields of artificial intelligence, integrative medicine, healthcare, and biomedical sciences.
The Editorial Board welcomes submissions from researchers, clinicians, academicians, healthcare professionals, engineers, and policy experts worldwide.
By submitting a manuscript to JAIIM, authors acknowledge that they have read, understood, and agreed to comply with these Author Guidelines, the Publication Ethics and Malpractice Statement, the Peer Review Policy, and all other editorial policies of the journal.
The journal continually reviews and updates its editorial policies to reflect evolving international standards in scholarly publishing and research integrity.f
The Journal of AI and Integrative Medicine invites high-quality original research, reviews, clinical studies, and interdisciplinary contributions in artificial intelligence and healthcare.
Submit Your Manuscript